Christian M Capitini MD

The Immunotherapy Hematopoietic Stem Cell Transplant Research Group, led by Dr. Christian M. Capitini at the University of Wisconsin-Madison, focuses on advanced cellular therapies, including natural killer (NK) cell and chimeric antigen receptor (CAR) T cell infusions, to combat pediatric cancers. Their innovative research aims to enhance treatment efficacy and mitigate adverse effects through engineered immune cells and real-time monitoring techniques.

In addition to clinical trials for high-risk B cell leukemia, the group investigates the development of non-viral CAR T cell generation for solid tumors and seeks to alleviate complications such as graft-versus-host disease and acute radiation syndrome using alternatively activated macrophages. With a commitment to training the next generation of researchers, the group offers opportunities for graduate students and postdoctoral fellows in the fields of cellular immunology and tumor modeling.

Generated from the website